SCTX insider trading

Scribe Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
22
Last 90 days
18
Buys / sells
27% / 0%
Market cap

SCTX insider activity at a glance

FilingIQ has scored 22 insider transactions for SCTX since Mar 13, 2026. The most recent filing in our index is dated Jul 28, 2026.

Across the full history, 6 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on SCTX insider trades is 65.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest SCTX Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Frequently asked

How many insider trades does FilingIQ track for SCTX?
FilingIQ tracks 22 Form 4 insider transactions for SCTX (Scribe Therapeutics, Inc.), covering filings from Mar 13, 2026 onwards. 18 of those were filed in the last 90 days.
Are SCTX insiders net buyers or net sellers?
Across the full Form 4 history for SCTX, 6 transactions (27%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does SCTX insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

Methodology & sources

Every SCTX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.